Effect of Hydroquinone on Hyperpigmentation

Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance (2023)

A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia (2023)

A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas (2022)

Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial (2021)

A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women (2020)

Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals (2019)

Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma (2019)

Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma (2017)

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone (2012)

Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma (2011)

Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening (2010)

A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma (2004)

The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream (1991)

Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma (1989)